Etude : ISKS / ET10000111



ATTENTION : pour chaque essai clinique, les éléments affichés ci-dessous ne sont pas exhaustifs, et le protocole fourni par le promoteur reste l’unique document à consulter pour mener à bien un essai clinique sur centre. Pour plus d'informations, contactez le référent du territoire concerné.


Acronyme
Nom
Traitement
Type d'étude
MÀJ
Présentation de l'étude
Acronyme : ISKS

Nom : ET10000111

Traitement :

Type d'étude : Qualité de vie / Observationnelle

Dernière MÀJ : 02/05/2019
Titre
Spécialité(s)
CIM10 - Localisation(s)
Informations principales
Titre : International Sarcoma Kindred Study - Etude internationale sur les formes familiales de sarcomes. Une étude prospective et multicentrique sur les cancers génétiques.

Spécialité : Toutes tumeurs solides
Localisation : C - Toutes localisations
Schéma
Phase
Stade
Ligne(s)
Informations complémentaires
Schéma : ISKS is a global genetic, biological, epidemiological and clinical resource for researchers to investigate important questions relating to the hereditary characteristics of sarcoma.

WHAT DOES PARTICIPATION IN ISKS INVOLVE?
- Completing a questionnaire
- A research assistant will ask you questions about your occupation, health, lifestyle, family medical history and your attitudes towards genetics and genetic research. This will take about 30 minutes. This may occur face to face or over the telephone. If necessary an interpreter can be arranged at any time.
- Providing a blood sample
- The research assistant will arrange to have the sample taken and they will give you written instructions as to how to go about this at your local pathology service or GP, at no cost to yourself. The blood will be stored in a central laboratory where genetic material (DNA and RNA) will be extracted and sometimes long living cell lines will be established.
- Allowing ISKS to obtain a small part of any cancer tissue that has been removed in the past, or may be removed in the future.
- This tissue is in excess of anything needed by the pathologist.
- Allowing medical information about yourself and deceased relatives to be collected from cancer registries and similar health organizations.
- Agreeing to identify relevant family members/friends and asking them if they want to be approached by ISKS to participate in the study.
- None of your personal details will be revealed to other family members.
- Agreeing to your specimens (blood and tissue) and information being used for cancer-related research purposes.

Phase : NA

Stade : NA

NA
Critères d'inclusion
Critères de non-inclusion
Critères d'inclusion et de non-inclusion
Critères d'inclusion : Anybody with adult-onset sarcoma (>15 years old) is eligible for the study. Family members may also be invited to participate if the person with sarcoma is under 45 years of age or there is a significant history of cancer in the family.

Critères de non-inclusion : Non renseigné
NCT
Promoteur
Coordonnateur
Informations relatives au promoteur
NCT :
NA
Promoteur :
Australasian Sarcoma Study Group (ASSG)
Type de sponsor : Institutionnel
-
00000 HORS FRANCE

Coordonnateur :
Centre investigateur
Investigateur
TEC / ARC / IDE
État
MÀJ
Informations relatives aux investigateurs
Centre investigateur :
Centre Oscar Lambret - 3 Rue Frédéric Combemale - 59000 LILLE

Investigateur :
Professeur Nicolas PENEL

TEC / ARC / IDE :
Unité Intégrée de Recherche Clinique
investigation@
o-lambret.fr
03.20.29.59.35

Ouverture de l'essai : OUVERT

MAJ : 20/03/2019

Australasian Sarcoma Study Group (ASSG) : http://www.australiansarcomagroup.org/about-assg.html